loading

Forte Biosciences Inc 주식(FBRX)의 최신 뉴스

pulisher
May 02, 2026

Wall Street Zen Upgrades Forte Biosciences (NASDAQ:FBRX) to "Sell" - MarketBeat

May 02, 2026
pulisher
Apr 30, 2026

Stock Traders Purchase High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Apr 30, 2026
pulisher
Apr 29, 2026

Forte Biosciences | DEF 14A: Definitive information statements - Moomoo

Apr 29, 2026
pulisher
Apr 29, 2026

[ARS] Forte Biosciences, Inc. SEC Filing - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Forte Biosciences (NASDAQ: FBRX) 2026 proxy seeks approval of larger equity plan - Stock Titan

Apr 29, 2026
pulisher
Apr 27, 2026

Is Forte Biosciences (FBRX) stock respecting technical levels | Q4 2025: Earnings Fall ShortCrowd Trend Signals - Newser

Apr 27, 2026
pulisher
Apr 27, 2026

Understanding the Setup: (FBRX) and Scalable Risk - Stock Traders Daily

Apr 27, 2026
pulisher
Apr 23, 2026

FBRX (Forte Biosciences Inc.) reports wider than expected Q4 2025 loss, with shares falling 3.52% following the earnings release.Financial Update - UBND thành phố Hải Phòng

Apr 23, 2026
pulisher
Apr 21, 2026

FBRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026
pulisher
Apr 18, 2026

Forte Biosciences Inc stock (US34960P1012): Is its immunology focus strong enough to unlock biotech - AD HOC NEWS

Apr 18, 2026
pulisher
Apr 16, 2026

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat

Apr 16, 2026
pulisher
Apr 16, 2026

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - MarketBeat

Apr 16, 2026
pulisher
Apr 16, 2026

The Technical Signals Behind (FBRX) That Institutions Follow - Stock Traders Daily

Apr 16, 2026
pulisher
Apr 14, 2026

Forte Biosciences Announces $150 Million Public Offering of Common Stock - Global Legal Chronicle

Apr 14, 2026
pulisher
Apr 13, 2026

Quarterly Recap: Will Forte Biosciences Inc outperform small cap indexes2026 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

Weekly Recap: Is Forte Biosciences Inc being accumulated by smart money2026 Analyst Calls & Advanced Technical Signal Analysis - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 11, 2026

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Apr 11, 2026
pulisher
Apr 10, 2026

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX) - Seeking Alpha

Apr 10, 2026
pulisher
Apr 10, 2026

Forte Biosciences: Stunning Bull Run Could Continue Thanks To Near-Term Data Readouts - Seeking Alpha

Apr 10, 2026
pulisher
Apr 10, 2026

BlackBerry Posts Upbeat Q4 Results, Joins STZ, MRVL And Other Big Stocks Moving Higher On Thursday - Sahm

Apr 10, 2026
pulisher
Apr 10, 2026

VIX Spike: Is Forte Biosciences Inc part of any major index2026 Pullback Review & Weekly Return Optimization Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Bull Bear: Does Forte Biosciences Inc have pricing powerOptions Play & Community Verified Trade Signals - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

Forte Biosciences Boosts Market Position with $150M Public Offering - timothysykes.com

Apr 09, 2026
pulisher
Apr 09, 2026

Forte Biosciences (NASDAQ: FBRX) registers 5.71M shares at $26.27 - Stock Titan

Apr 09, 2026
pulisher
Apr 09, 2026

TPG closes $18 billion take-private deal, publicly traded biotech to raise $150M - The Business Journals

Apr 09, 2026
pulisher
Apr 09, 2026

Brookline Capital Markets Cuts Forte Biosciences FY2026 Earnings Forecast - National Today

Apr 09, 2026
pulisher
Apr 09, 2026

Forte Biosciences Prices $150 Million Public Offering - TipRanks

Apr 09, 2026
pulisher
Apr 09, 2026

Forte Biosciences Prices $150 Million Stock Offering at $26.27; Underwriting Led by Guggenheim - TradingView

Apr 09, 2026
pulisher
Apr 09, 2026

Forte Biosciences (NASDAQ: FBRX) prices $150M common stock sale - Stock Titan

Apr 09, 2026
pulisher
Apr 09, 2026

Forte Biosciences prices 5.71M shares at $26.27 in $150M capital raise - MSN

Apr 09, 2026
pulisher
Apr 09, 2026

Forte Biosciences Prices $150 Million Stock Offering - marketscreener.com

Apr 09, 2026
pulisher
Apr 08, 2026

Forte Biosciences prices $150M stock offering at $26.27/share By Investing.com - Investing.com India

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences Announces Pricing of $150 Million Public Offering - Weekly Voice

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences prices $150M stock offering at $26.27/share - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences announces pricing of $150 million public offering - marketscreener.com

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences Announces Pricing Of $150 Million Public Offering - TradingView

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences launches public stock offering By Investing.com - Investing.com South Africa

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences launches public stock offering - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences (FBRX) files prospectus supplement to sell common stock - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

Forte Biosciences Announces Proposed Public Offering - marketscreener.com

Apr 08, 2026
pulisher
Apr 08, 2026

Drug developer Forte launches stock sale to fund clinical research - Stock Titan

Apr 08, 2026
pulisher
Apr 07, 2026

Forte Biosciences Inc stock: What investors need to know in biotech volatility - AD HOC NEWS

Apr 07, 2026
pulisher
Apr 07, 2026

Buybacks Report: Will Forte Biosciences Inc announce a stock splitShare Buyback & Daily Entry Point Alerts - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 06, 2026

Is Forte Biosciences (FBRX) Stock Near Resistance | Price at $25.77, Up 0.74%Professional Trade Ideas - Newser

Apr 06, 2026
pulisher
Apr 05, 2026

Tech Rally: Is Forte Biosciences Inc trading at a discount2026 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 05, 2026

Published on: 2026-04-05 11:22:35 - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 05, 2026

Precision Trading with Forte Biosciences Inc. (FBRX) Risk Zones - Stock Traders Daily

Apr 05, 2026
pulisher
Apr 04, 2026

Forte Biosciences and Pasithea Therapeutics Face Off in Financial Comparison - National Today

Apr 04, 2026
pulisher
Apr 03, 2026

Forte Biosciences (NASDAQ: FBRX) CFO exercises RSUs, 134 shares withheld - Stock Titan

Apr 03, 2026
pulisher
Apr 03, 2026

Forte Biosciences (FBRX) director boosts stake after RSU vesting - Stock Titan

Apr 03, 2026
pulisher
Apr 02, 2026

Guggenheim reiterates Forte Biosciences stock rating ahead of data By Investing.com - Investing.com India

Apr 02, 2026
pulisher
Apr 02, 2026

Guggenheim reiterates Forte Biosciences stock rating ahead of data - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Forte Biosciences (FBRX) - The Globe and Mail

Apr 02, 2026
pulisher
Apr 02, 2026

Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - MarketBeat

Apr 02, 2026
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
자본화:     |  볼륨(24시간):